[1]孙天恒?张疆华?汤宝鹏.植入式心律转复除颤器术后焦虑研究的进展[J].心血管病学进展,2023,(12):1069.[doi:10.16806/j.cnki.issn.1004-3934.2023.12.004]
　SUN Tianheng,ZHANG Jianghua,TANG Baopeng.Advances in the Study of Postoperative Anxiety with?mplantable Cardioverter-Defibrillators[J].Advances in Cardiovascular Diseases,2023,(12):1069.[doi:10.16806/j.cnki.issn.1004-3934.2023.12.004]
点击复制

植入式心律转复除颤器术后焦虑研究的进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2023年12期
页码:
1069
栏目:
综述
出版日期:
2023-12-25

文章信息/Info

Title:
Advances in the Study of Postoperative Anxiety with?mplantable Cardioverter-Defibrillators
作者:
孙天恒?张疆华?汤宝鹏
(新疆医科大学第一附属医院心脏中心起搏电生理科 新疆心电生理与心脏重塑重点实验室,新疆 乌鲁木齐 830054)
Author(s):
SUN Tianheng; ZHANG Jianghua; TANG Baopeng
?Department of Pacing and Electrophysiology,Department of Cardiac Electrophysiology and Remodeling,TheFirst Affiliated Hospital of Xinjiang Medical University,Urumqi 830054 XinjiangChina)
关键词:
植入型心律转复除颤器; 焦虑; 心理干预
Keywords:
Implantable cardioverter defibrillator; Anxiety; Psychological intervention
DOI:
10.16806/j.cnki.issn.1004-3934.2023.12.004
摘要:
目前,植入式心律转复除颤器是预防心源性猝死的有效措施。尽管它提高了患者的生存效益,但由于心理及生物等各种因素,部分患者出现了焦虑症状,尤其是经历电击的患者。焦虑症状与不良心脏结局相关，降低了患者的生活质量，并增加再入院率和医疗费用,从而降低了植入式心律转复除颤器的治疗效益。此外焦虑也是除颤器电击治疗的触发因素,电击、焦虑互为因果形成恶性循环。尽管CBT治疗植入除颤器患者的焦虑症状有效,但临床依从性差,而网络干预途径有望成为新趋势,但尚未完善。因此心内科医师有必要对植入除颤器患者术后的焦虑症状进行筛查,并详细记录他们的心脏病史及除颤器随访记录,以便分析植入除颤器后焦虑相关的因素并进行干预,提高植入除颤器患者的治疗效益。
Abstract:
Currently, implantable cardioverter-defibrillator is an effective measure to prevent sudden cardiac death. Although it improves the survival benefit of patients, some patients experience anxiety symptoms, especially those who experience electric shocks, due to various psychological and biological factors. Anxiety symptoms are associated with poor cardiac outcomes, reducing the quality of life of patients and increasing readmission rates and healthcare costs, thereby reducing the therapeutic benefit of implantable cardioverter defibrillators. In addition, anxiety is a trigger for defibrillator shock therapy, and shock and anxiety are mutually reinforcing in a vicious cycle. Although CBT is effective in treating anxiety in patients with implanted defibrillators,clinical adherence is poor, and web-based interventions are a promising new trend that has not yet been perfected. Therefore, it is necessary for cardiologists to screen defibrillator implantation patients for postoperative anxiety symptoms and record their cardiac history and defibrillator follow-up records in order to analyse the factors related to anxiety after defibrillator implantation and intervene in order to improve the benefits of treatment for defibrillator implantation patients

参考文献/References:

[1] Schulz SM,Ritter O,Zniva R,et al. Efficacy of a web-based intervention for improving psychosocial well-being in patients with implantable cardioverter-defibrillators:the randomized controlled ICD-FORUM trial[J]. Eur Heart J,2020,41(11):1203-1211.

[2] Wong CX,Brown A,Lau DH,et al. Epidemiology of sudden cardiac death:global and regional perspectives[J]. Heart Lung Circ,2019,28(1):6-14.

[3] Hua W,Zhang LF,Wu YF,et al. Incidence of sudden cardiac death in China:analysis of 4 regional populations[J]. J Am Coll Cardiol,2009,54(12):1110-1118.

[4] Wang M ,Peterson DR,R osero S,et al. Effectiveness of implantable cardioverter-defibrillators to reducemortality in patients with long QT syndrome[J]. J Am Coll Cardiol,2021,78(21):2076-2088.

[5] van der lingen A CJ,Rijnierse M T,Hooghiemstra A M,et al. The link between cardiac status and depression and anxiety in implantable cardioverter defibrillator patients:design and first results of the PSYCHE-ICD study[J]. J Psychosom Res,2023,167:111182.

[6] Godemann F,B utter C,L ampe F,et al. Determinants of the quality of life (QoL) in patients with an implantable cardioverter/defibrillator (ICD) [J]. Qual Life Res,2004,13(2):411-416.

[7] Berg S K,Herning M,S vendsen J H,et al. The Screen-ICD trial. Screening for anxiety and cognitive therapy intervention for patients with implanted cardioverter defibrillator (ICD):a randomised controlled trial protocol[J]. BMJ Open,2016,6(10):e013186.

[8] Magyar-Russell G,T hombs B D,Cai J X,et al. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators:a systematic review[J]. J Psychosom Res,2011,71(4):223-231.

[9] Guo X,T rip C,H uber N L,et al. Patient reported outcomes and quality of life in Chinese patients with implantable cardioverter defibrillators(?)[J]. Heart Lung,2021,50(1):153-158.

[10] 向晋涛,江洪. 埋藏式心脏转复除颤器治疗的心理问题[C].中国心脏起搏与心电生理杂志,广西医学会心血管病学分会,广西医学会心脏起搏与电生理学分会,广西医科大学第一附属医院.全国心律失常的现代诊疗新进展专题会议暨广西心脏节律论坛（2011）资料汇编,2011:4.



[11] Sola C L,Bostwick J M. Implantable cardioverter-defibrillators,induced anxiety,and quality of life[J]. Mayo Clin Proc,2005,80(2):232-237.

[12] Denollet J. DS14 :standard assessment of negative affectivity,social inhibition,and type D personality[J]. Psychosom Med,2005,67(1):89-97.

[13] Miller J L,Thylén I,M oser D K. Gender disparities in symptoms of anxiety,depression,and quality of life in defibrillator recipients[J]. Pacing Clin Electrophysiol,2016,39(2):149-159.

[14] 郭希娟,侯翠红,李静,等.100例心律转复除颤器植入患者放电焦虑的影响因素分析[J]. 护理学报,2016,23(22):68-71.

[15] Starrenburg A H,Kraaier K,P edersen S S,et al. Association of psychiatric history and type D personality with symptoms of anxiety,depression,and health status prior to ICD implantation[J]. Int J Behav Med,2013,20(3):425-433.

[16] Wong M F. Factors associated with anxiety and depression among patients with implantable cardioverter defibrillator[J]. J Clin Nurs,2017,26(9-10):1328-1337.

[17] Burns J L,Sears S F,Sotile R,et al. Do patients accept implantable atrial defibrillation therapy? Results from the patient atrial shock survey of acceptance and tolerance (PASSAT) study[J]. J Cardiovasc Electrophysiol. 2004,15(3):286-291.

[18] Hsueh B,C hen R,J o Y,et al. Cardiogenic control of affective behavioural state [J]. Nature,2023,615(7951):292-299.

[19] Kindermann I,W edeg?rtner S M,Bernhard B,et al. Changes in quality of life,depression,general anxiety,and heart-focused anxiety after defibrillator implantation [J]. ESC Heart Fail,2021,8(4):2502-2512.

[20] Y-Hassan S,Tornvall P. Epidemiology,pathogenesis,and management of takotsubo syndrome [J]. Clin Auton Res ,2018,28(1):53-65.

[21] Rocha E A,Costa I P. Florida shock anxiety scale for patients with implantable cardioverter-defibrillator-appreciating the psychosocial aspects[J]. Arq Bras Cardiol,2020,114(5):773-774.

[22] Elsokkari I,S app J L. Electrical storm:prognosis and management[J]. Prog Cardiovasc Dis,2021,66:70-79.

[23] Trippk C,H uber N L,Kuhl E A,et al. Measuring ICD shock anxiety:status update on the Florida Shock Anxiety Scale after over a decade of use[J]. Pacing Clin Electrophysiol,2019,42(10):1294-1301.

[24] Chair S Y,Lee C K,Choi K C,et al. Quality of life outcomes in chinese patients with implantable cardioverter defibrillators[J]. Pacing Clin Electrophysiol,2011,34(7):858-867.

[25] Maia A C,Braga A A,Soares-Filho G,et al. Efficacy of cognitive behavioral therapy in reducing psychiatric symptoms in patients with implantable cardioverter defibrillator :an integrative review[J]. Braz J Med Biol Res,2014,47(4):265-272.

[26] Schulz S M,Massa C,G rzbiela A,et al. Implantable cardioverter defibrillator shocks are prospective predictors of anxiety [J]. Heart Lung,2013,42(2):105-111.

[27] Andrews G,B asu A,C uijpers P,et al. Computer therapy for the anxiety and depression disorders is effective,acceptable and practical health care :an updated meta-analysis[J]. J Anxiety Disord,2018,55:70-78.

[28] Abdelwahab A,S app J. Ventricular tachycardia with ICD shocks:when to medicate and when to ablate[J]. Curr Cardiol Rep,2017,19(11):105.

[29] Reddy V Y,Reynolds M R,Neuzzil P,et al. Prophylactic catheter ablation for the prevention of defibrillator therapy [J]. N Engl J Med,2007,357(26):2657-2665.

[30] Kosiuk J,N edios S,D arma A,et al. Impact of single atrial fibrillation catheter ablation on implantable cardioverter defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies [J]. Europace,2014,16(9):1322-1326.

[31] Ruwald A C,Schuger C,M oss A J,et al. Mortality reduction in relation to implantable cardioverter defibrillator programming in the multicenter automatic defibrillator implantation trial—Reduce inappropriate therapy (MADIT-RIT)[J]. Circ Arrhythm Electrophysiol,2014,7(5):785-792.

[32] Tan V H,Wilton S B,Kuriachan V,et al. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality :a systematic review and meta-analysis[J]. Circ Arrhythm Electrophysiol,2014,7(1):164-170.

[33] Kooiman K M,Knops R E,Olde N ordkamp L,et al. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented :implications for management[J]. Heart Rhythm,2014,11(3) :426-434.

[34] Thomas R J,Beatty A L,Beckie T M,et al. Home-based cardiac rehabilitation:a scientific statement from the american association of cardiovascular and pulmonary rehabilitation,the american heart association,and the american college of cardiology[J]. Circulation ,2019,74(1):133-153.

[35] Nielsen K M,Zwisler A D,Taylor R S,et al. Exercise-based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator[J]. Cochrane Database Syst Rev,2019,2(2):CD011828.

[36] Carnes C A,Pickworth K K,Votolato N A,et al. Elevated defibrillation threshold with venlafaxine therapy[J]. Pharmacotherapy,2004,24(8):1095-1098.

相似文献/References:

[1]王宇 周思维 张莎 吴弘.植入型心律转复除颤器在心肌梗死后心脏性猝死中的研究进展[J].心血管病学进展,2020,(1):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
　WANG Yu,ZHOU Siwei,ZHANG Sha,et al.Implantable Cardioverter Defibrillator in Sudden Cardiac Death after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(12):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
[2]赵薇 陈芸霖 殷跃辉.焦虑与心房颤动相互作用的研究进展[J].心血管病学进展,2021,(2):123.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.007]
　ZHAO Wei,CHEN Yunlin,YIN Yuehui.Interaction Between Anxiety and Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(12):123.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.007]
[3]董天慧 周力 陈晖.焦虑与冠状动脉痉挛：不容忽视的风险[J].心血管病学进展,2021,(12):1069.[doi:10.16806/j.cnki.issn.1004-3934.2021.12.004]
　DONG Tianhui,ZHOU Li,Chen Hui.Anxiety and Coronary Artery Spasm:a Risk Not To Be Ignored[J].Advances in Cardiovascular Diseases,2021,(12):1069.[doi:10.16806/j.cnki.issn.1004-3934.2021.12.004]
[4]素比努尔·吾布力卡斯木 李耀东.肾去交感神经术治疗植入型心律转复除颤器植入术后电风暴的研究进展[J].心血管病学进展,2023,(3):208.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.004]
　Subinuer·Wubulikasimu,LI Yaodong.Renal Sympathetic Denervation in Treatment of Electrical Storm After Implantable Cardioverter Defibrillator Implantation[J].Advances in Cardiovascular Diseases,2023,(12):208.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.004]
[5]李克研 丁宛萱 董颖雪.中国成人肥厚型心肌病患者的猝死风险评估与预防[J].心血管病学进展,2024,(2):111.[doi:10.16806/j.cnki.issn.1004-3934.2024.02.004]
　LI Keyan,DING Wanxuan,DONG Yingxue.Risk Assessment and Prevention of Sudden Death in Chinese Adults with Hypertrophic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2024,(12):111.[doi:10.16806/j.cnki.issn.1004-3934.2024.02.004]

更新日期/Last Update: 2024-01-19